Tag:
hepatitis C
Latest Headlines
Latest Headlines
World has huge unmet vaccine needs
While vaccines in some form or another have been used since the 16th century, there are still areas of unmet need. "The world still has no vaccine for HIV/AIDS and hepatitis C, and there's need for a better vaccine against influenza," as Australian Nobel Laureate Peter Doherty told The Times of India .
Hep C vaccine heads into further clinical trials
Hepatitis C virus infection is spread through the blood, and it can lead to liver cirrhosis and is the leading cause of liver cancer. Okairos, a spinout from Merck ( $MRK ), is starting a Phase I/II clinical trial for its preventive hepatitis C vaccine for people at risk of infection, which it says is the first multi-center, double-blinded, randomized, placebo-controlled trial of a vaccine to prevent HCV infection.
Merck spinout nails promising study on hep C vaccine
A group of European investigators working in league with a small biotech spun out of Merck four years ago has claimed an early-stage success with a small human trial that has generated positive
Discovery reveals possible way to engineer blood vessels to deliver drugs
Children's Hospital Boston researchers believe they have may have found a way to genetically engineer blood vessels to secrete recombinant, protein-based drugs directly into the bloodstream--on...
Inovio, VGX ink hep B and C vaccine deal
Blue Bell, PA-based Inovio Pharmaceuticals and VGX International will collaborate on the development of Inovio's synthetic vaccines for hepatitis B and hepatitis C. Financial details of the deal were
Researchers find weakness in hep C virus
Researchers from the University of New South Wales say they've discovered not one but two "Achilles heels" within the hepatitis C virus. The diseases' first weak point is in transmission, when it
Epixis' hep C vaccine shows early promise
French biotech company Epixis says it's used its experimental hepatitis C vaccine to fight off a variety of hepatitis C viruses in animal trials by spawning neutralizing antibodies. The developer is
Inovio, Transgene and ChronTech enter HepC pact
Using a variation of the typical booster shot vaccination process, Inovio Pharmaceuticals, Transgene and ChronTech Pharma have joined together for a Phase I study of a therapeutic hepatitis C
GlobeImmune HCV vax shows promise in trial
GlobeImmune's GI-5005, the company's investigational Tarmogen product, improved sustained virologic response by 12 percent in patients with genotype 1 chronic hepatitis C virus infection who had
OraSure gets thumbs up for HCV test
Bethlehem, PA-based OraSure Technologies (NASDAQ:OSUR) has received the FDA's OK for its OraQuick hepatitis C rapid antibody test. It is the the first rapid HCV test approved by the FDA for use in
